Ammonia Solution, Strong

Ammonia Solution, Strong

SCHEMBL524093

CCCCC(Cl)(CCCC)CCCC.N

nearest known ligand 0.39

Full drug profile on Sugi Atlas →

Predicted protein targets (top 9)

geneUniProtsupporting neighboursconfidence
FDPS P14324 3/20 0.39
TSHR P16473 4/20 0.38
LMNA P02545 1/20 0.38
TDP1 Q9NUW8 1/20 0.37
THRB P10828 1/20 0.35
ALDH1A1 P00352 2/20 0.33
SMPD1 P17405 2/20 0.31
ESR1 P03372 1/20 0.31
ESR2 Q92731 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5528900 0.97 TSHR (0.40) FDPSTSHRLMNATDP1THRB
Ammonia Solution, Strong SCHEMBL11836898 0.94 FDPS (0.39) FDPSTSHRTHRBALDH1A1SMPD1
Ammonia Solution, Strong SCHEMBL11827544 0.94 FDPS (0.39) FDPSTSHRTHRBALDH1A1SMPD1
SCHEMBL27696187 0.93 FDPS (0.39) FDPSTSHRLMNATDP1THRB
Phosphine SCHEMBL6693796 0.93 FDPS (0.39) FDPSTSHRLMNATDP1THRB
SCHEMBL27810873 0.90 FDPS (0.37) FDPSTSHRLMNATDP1THRB
Ammonia Solution, Strong SCHEMBL11830303 0.90 TSHR (0.41) FDPSTSHRLMNATDP1THRB
Ammonia Solution, Strong SCHEMBL1094258 0.88 TSHR (0.47) FDPSTSHRTHRBALDH1A1SMPD1
Ammonia Solution, Strong SCHEMBL11831224 0.88 TSHR (0.47) FDPSTSHRTHRBALDH1A1SMPD1
Ammonia Solution, Strong SCHEMBL11830969 0.88 TSHR (0.47) FDPSTSHRTHRBALDH1A1SMPD1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 174 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-116178587-B Quaternary ammonium glycogen, composite antibacterial hydrogel and preparation method and application thereof 江南大学 2025-04-11 CN claimed
CN-119144153-A Flame-retardant antistatic polyamide and preparation method thereof 中化学科学技术研究有限公司 2024-12-17 CN claimed
CN-117039207-B Battery, iodine electrode material and preparation method of electrolyte 广东工业大学 2024-07-30 CN claimed
CN-118239909-A Ketone-containing bisfuranyl monomer compound, preparation method thereof, electronic packaging adhesive and application thereof 中国科学技术大学 2024-06-25 CN claimed
CN-117039207-A Battery, iodine electrode material and preparation method of electrolyte 广东工业大学 2023-11-10 CN claimed
CN-115057867-B Electrochromic compound, device, preparation method and application thereof 吉林大学 2023-09-15 CN claimed
WO-2023159094-A2 PROCESS OF MAKING 3α-HYDROXY-3β-METHOXYMETHYL-21-(1'- IMIDAZOLYL)-5α-PREGNAN-20-ONE PRAXIS PRECISION MEDICINES, INC. (US) 2023-08-24 WO claimed
CN-116178587-A Quaternary ammonium glycogen, composite antibacterial hydrogel and preparation method and application thereof 江南大学 2023-05-30 CN claimed
US-20210369582-A1 METHODS AND COMPOSITIONS FOR REMOVING COLOR FROM COLOR-TREATED HAIR L'OREAL (FR) 2021-12-02 US claimed
CN-113683879-A High-strength flame-retardant antistatic polyurethane composite material and preparation method and application thereof 重庆科聚孚新材料有限责任公司 2021-11-23 CN claimed
US-11173102-B1 Methods and compositions for removing color from color-treated hair L'OREAL (FR) 2021-11-16 US claimed
US-11154479-B1 Methods of removing color from color-treated hair L'OREAL (FR) 2021-10-26 US claimed
CN-112156809-A Ionic liquid modified activated carbon loaded gold catalyst and application thereof in catalyzing acetylene hydrochlorination 西安凯立新材料股份有限公司 2021-01-01 CN claimed
WO-2015180585-A9 METHOD OF PRODUCING THIAMETHOXAM ROTAM AGROCHEM INTERNATIONAL COMPANY LIMITED (CN) 2016-12-15 WO claimed
US-9242926-B2 Processes for the preparation of lacosamide and intermediates thereof CADILA HEALTHCARE LIMITED (IN) 2016-01-26 US claimed
WO-2015180585-A1 METHOD OF PRODUCING THIAMETHOXAM ROTAM AGROCHEM INTERNATIONAL COMPANY LIMITED (CN) 2015-12-03 WO claimed
US-20140296572-A1 PROCESSES FOR THE PREPARATION OF LACOSAMIDE AND INTERMEDIATES THEREOF CADILA HEALTHCARE LIMITED (IN) 2014-10-02 US claimed
EP-2305779-A2 Method for desulfurization of hydrocarbon oils General Electric Company (US) 2011-04-06 EP claimed
US-20110073526-A1 Method for Desulfurization of Hydrocarbon Oils GENERAL ELECTRIC COMPANY (US) 2011-03-31 US claimed
JP-4227856-A None JP disclosed
US-20260125363-A1 PROCESSES FOR MAKING MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR VERTEX PHARMA (US) 2026-05-07 US disclosed
US-12415798-B2 Processes for making modulators of cystic fibrosis transmembrane conductance regulator VERTEX PHARMACEUTICALS INCORPORATED (US) 2025-09-16 US disclosed
CN-116178587-B Quaternary ammonium glycogen, composite antibacterial hydrogel and preparation method and application thereof 江南大学 2025-04-11 CN disclosed
CN-119421934-A Inorganic microparticle dispersion 住友化学株式会社 2025-02-11 CN disclosed
CN-119144153-A Flame-retardant antistatic polyamide and preparation method thereof 中化学科学技术研究有限公司 2024-12-17 CN disclosed
US-20240368123-A1 AROMATIC RING-CONTAINING BIOLOGICAL ANTAGONIST, AND PREPARATION METHOD THEREFOR AND USE THEREOF JIANGSU HANSOH PHARMACEUTICAL GROUP CO., LTD. (CN) 2024-11-07 US disclosed
CN-118488865-A Foam stabilizing composition for fluorine-free fire extinguishing foam 美国陶氏有机硅公司 2024-08-13 CN disclosed
EP-4393920-A1 AROMATIC RING-CONTAINING BIOLOGICAL ANTAGONIST, AND PREPARATION METHOD THEREFOR AND USE THEREOF Shanghai Hansoh Biomedical Co., Ltd. (CN) 2024-07-03 EP disclosed
CN-118239909-A Ketone-containing bisfuranyl monomer compound, preparation method thereof, electronic packaging adhesive and application thereof 中国科学技术大学 2024-06-25 CN disclosed
CN-117051260-B Treatment process of lithium-containing multi-metal solution 徐浩 2024-05-24 CN disclosed
CN-118019777-A Process for producing polyether polymer containing thiol group 东丽精细化工株式会社 2024-05-10 CN disclosed
CN-114591181-B Method for preparing high-purity ionic liquid 原力新材料(合肥)有限公司 2024-04-19 CN disclosed
CN-117820121-A Synthesis process of 2-nitrophenoxy acetone 威尔(福建)生物有限公司 2024-04-05 CN disclosed
CN-111117594-B Electrochromic material and electrochromic device based on dynamic metal-ligand complexation 吉林大学 2024-03-26 CN disclosed
CN-111757874-B Methods for preparing modulators of cystic fibrosis transmembrane conductance regulator 弗特克斯药品有限公司 2024-03-08 CN disclosed
CN-117607323-A Detection method for sodium docusate content 湖南省药品检验检测研究院 2024-02-27 CN disclosed
CN-117597373-A Production of PU foam 赢创运营有限公司 2024-02-23 CN disclosed
US-20240025877-A1 PROCESSES FOR MAKING MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR VERTEX PHARMACEUTICALS INCORPORATED 2024-01-25 US disclosed
CN-113651781-B Method for preparing 5-hydroxymethylfurfural from glucose 广东工业大学 2024-01-19 CN disclosed
CN-117355557-A Polymer composition, epoxy resin composition, curing agent for epoxy resin, and quick-setting adhesive 东丽精细化工株式会社 2024-01-05 CN disclosed
CN-111051280-B Process for preparing pyrrolidine compounds 弗特克斯药品有限公司 2023-12-22 CN disclosed
CN-113880774-B Preparation method of phenyl isoxazoline compound 沈阳中化农药化工研发有限公司 2023-12-08 CN disclosed
CN-117051260-A Treatment process of lithium-containing multi-metal solution 徐浩 2023-11-14 CN disclosed
WO-2023159094-A2 PROCESS OF MAKING 3α-HYDROXY-3β-METHOXYMETHYL-21-(1'- IMIDAZOLYL)-5α-PREGNAN-20-ONE PRAXIS PRECISION MEDICINES, INC. (US) 2023-08-24 WO disclosed
CN-116178587-A Quaternary ammonium glycogen, composite antibacterial hydrogel and preparation method and application thereof 江南大学 2023-05-30 CN disclosed
CN-111435705-B Repairing agent and repairing method thereof and method for preparing photoelectric film 杭州纤纳光电科技有限公司 2023-04-07 CN disclosed
US-11465985-B2 Processes for making modulators of cystic fibrosis transmembrane conductance regulator VERTEX PHARMACEUTICALS INCORPORATED (US) 2022-10-11 US disclosed
CN-114146726-A High-dispersion ruthenium-based catalyst and preparation method and application thereof 内蒙古鄂尔多斯电力冶金集团股份有限公司 2022-03-08 CN disclosed
US-20210369582-A1 METHODS AND COMPOSITIONS FOR REMOVING COLOR FROM COLOR-TREATED HAIR L'OREAL (FR) 2021-12-02 US disclosed
CN-109475574-B Crosslinkable coating compositions formulated with dormant carbamate initiators 海名斯精细化工公司 2021-11-16 CN disclosed
US-11173102-B1 Methods and compositions for removing color from color-treated hair L'OREAL (FR) 2021-11-16 US disclosed
US-11154479-B1 Methods of removing color from color-treated hair L'OREAL (FR) 2021-10-26 US disclosed
US-20210246117-A1 PROCESSES FOR MAKING MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR VERTEX PHARMACEUTICALS (SAN DIEGO) LLC 2021-08-12 US disclosed
EP-3310792-B1 PROCESS FOR PREPARING AN ACRYLOYLOXYSILANE DOW SILICONES CORP (US) 2021-07-21 EP disclosed
EP-3594207-B1 ELECTROCHEMICAL ENERGY STORAGE DEVICES GENTEX CORP (US) 2021-06-30 EP disclosed
EP-3310793-B1 PROCESS FOR PREPARING AN ACRYLOYLOXYSILANE DOW SILICONES CORP (US) 2021-06-09 EP disclosed
CN-109504015-B Electrochromic polymer material based on combination strategy and preparation of electrochromic device 常州铱视光电科技有限公司 2021-05-11 CN disclosed
US-10971718-B2 Electrochemical energy storage devices GENTEX CORPORATION (US) 2021-04-06 US disclosed
CN-112156809-A Ionic liquid modified activated carbon loaded gold catalyst and application thereof in catalyzing acetylene hydrochlorination 西安凯立新材料股份有限公司 2021-01-01 CN disclosed
CN-112086564-A Passivating agent and passivation method thereof and method for preparing semiconductor film 杭州纤纳光电科技有限公司 2020-12-15 CN disclosed
EP-3720849-A2 PROCESSES FOR MAKING MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR Vertex Pharmaceuticals Incorporated (US) 2020-10-14 EP disclosed
CN-111435705-A Repairing agent and repairing method thereof and method for preparing photoelectric film 杭州纤纳光电科技有限公司 2020-07-21 CN disclosed
CN-110958913-A Coating system 海名斯精细化工公司 2020-04-03 CN disclosed
US-20200050070-A1 ELECTROCHEMICAL ENERGY STORAGE DEVICES GENTEX CORPORATION 2020-02-13 US disclosed
US-10481456-B2 Electrochemical energy storage devices GENTEX CORPORATION (US) 2019-11-19 US disclosed
EP-3164390-B1 ELECTROCHROMIC DEVICES AND COMPOUNDS THEREFOR GENTEX CORP (US) 2019-09-18 EP disclosed
WO-2019113476-A2 PROCESSES FOR MAKING MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR VERTEX PHARMACEUTICALS INCORPORATED (US) 2019-06-13 WO disclosed
EP-3478299-A1 CROSSLINKABLE COATING COMPOSITIONS FORMULATED WITH DORMANT CARBAMATE INITIATOR Elementis Specialties, Inc. (US) 2019-05-08 EP disclosed
US-10273254-B2 Process for preparing an acryloyloxysilane DOW CORNING CORPORATION (US) 2019-04-30 US disclosed
US-10246473-B2 Process for preparing an acryloyloxysilane DOW CORNING CORPORATION (US) 2019-04-02 US disclosed
WO-2018231927-A1 CLEAR COAT FORMULATIONS FOR USE OVER NAIL POLISH ELEMENTIS SPECIALTIES, INC. (US) 2018-12-20 WO disclosed
US-20180157139-A1 ELECTROCHEMICAL ENERGY STORAGE DEVICES GENTEX CORPORATION 2018-06-07 US disclosed
US-20180155371-A1 PROCESS FOR PREPARING AN ACRYLOYLOXYSILANE DOW SILICONES CORPORATION 2018-06-07 US disclosed
US-20180134734-A1 PROCESS FOR PREPARING AN ACRYLOYLOXYSILANE DOW SILICONES CORPORATION 2018-05-17 US disclosed
US-9964828-B2 Electrochemical energy storage devices GENTEX CORPORATION (US) 2018-05-08 US disclosed
EP-3310792-A1 PROCESS FOR PREPARING AN ACRYLOYLOYLOXYSILANE Dow Corning Corporation (US) 2018-04-25 EP disclosed
EP-3310793-A1 PROCESS FOR PREPARING AN ACRYLOYLOXYSILANE Dow Corning Corporation (US) 2018-04-25 EP disclosed
WO-2018005077-A1 CROSSLINKABLE COATING COMPOSITIONS FORMULATED WITH DORMANT CARBAMATE INITIATOR ELEMENTIS SPECIALTIES, INC. (US) 2018-01-04 WO disclosed
EP-3164390-A1 ELECTROCHEMICAL ENERGY STORAGE DEVICES Gentex Corporation (US) 2017-05-10 EP disclosed
WO-2016205642-A1 PROCESS FOR PREPARING AN ACRYLOYLOYLOXYSILANE DOW CORNING CORPORATION (US) 2016-12-22 WO disclosed
WO-2016205648-A1 PROCESS FOR PREPARING AN ACRYLOYLOXYSILANE DOW CORNING CORPORATION (US) 2016-12-22 WO disclosed
WO-2015180585-A9 METHOD OF PRODUCING THIAMETHOXAM ROTAM AGROCHEM INTERNATIONAL COMPANY LIMITED (CN) 2016-12-15 WO disclosed
EP-2762482-B1 PROCESS FOR PURIFYING AN ACRYLOYLOXYSILANE DOW CORNING (US) 2016-10-26 EP disclosed
US-9249164-B2 Process for preparing an acryloyloxysilane DOW SILICONES CORPORATION 2016-02-02 US disclosed
WO-2015183821-A1 ELECTROCHEMICAL ENERGY STORAGE DEVICES GENTEX CORPORATION (US) 2015-12-03 WO disclosed
WO-2015180585-A1 METHOD OF PRODUCING THIAMETHOXAM ROTAM AGROCHEM INTERNATIONAL COMPANY LIMITED (CN) 2015-12-03 WO disclosed
US-20150346573-A1 ELECTROCHEMICAL ENERGY STORAGE DEVICES GENTEX CORPORATION 2015-12-03 US disclosed
US-8940889-B2 Process for producing benzo [b] [1,4] diazepine-2,4-dione compound OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2015-01-27 US disclosed
EP-2188314-B1 CONVERSION METHOD PETROLIAM NASIONAL BERHAD PETRONAS (MY) 2014-10-22 EP disclosed
EP-2621936-B1 PROCESS FOR PREPARING AN ACRYLOYLOXYSILANE DOW CORNING (US) 2014-10-22 EP disclosed
EP-2762482-A1 Process for purifying an acryloyloxysilane Dow Corning Corporation (US) 2014-08-06 EP disclosed
US-8796447-B2 Process for producing benzo[B][1,4]diazepine-2,4-dione compound OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2014-08-05 US disclosed
US-20140194621-A1 PROCESS FOR PRODUCING BENZO [B] [1,4] DIAZEPINE-2, 4-DIONE COMPOUND OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2014-07-10 US disclosed
US-8574368-B2 Conversion method PETROLIAM NASIONAL BERHARD (PETRONAS) (MY) 2013-11-05 US disclosed
EP-2621936-A2 PROCESS FOR PREPARING AN ACRYLOYLOXYSILANE Dow Corning Corporation (US) 2013-08-07 EP disclosed
US-20130184482-A1 Process For Preparing An Acryloyloxysilane DOW CORNING CORPORATION (US) 2013-07-18 US disclosed
US-8409426-B2 Treatment of crude oil fractions, fossil fuels, and products thereof PETROSONICS, LLC (US) 2013-04-02 US disclosed
EP-1727782-B1 METHOD OF PRODUCING AMINOPHENOL COMPOUNDS OTSUKA PHARMA CO LTD (JP) 2012-08-22 EP disclosed
EP-2468733-A1 PROCESS FOR PRODUCING BENZO[B][1,4]DIAZEPINE-2,4-DIONE COMPOUND Otsuka Pharmaceutical Co., Ltd. (JP) 2012-06-27 EP disclosed
US-20120149899-A1 PROCESS FOR PRODUCING BENZO[B][1,4]DIAZEPINE-2,4-DIONE COMPOUND OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2012-06-14 US disclosed
WO-2012050761-A2 PROCESS FOR PREPARING AN ACRYLOYLOXYSILANE DOW CORNING CORPORATION (US) 2012-04-19 WO disclosed
US-20120029247-A1 CONVERSION METHOD THE QUEEN'S UNIVERSITY OF BELFAST (IE) 2012-02-02 US disclosed
US-20110108465-A1 TREATMENT OF CRUDE OIL FRACTIONS, FOSSIL FUELS, AND PRODUCTS THEREOF PETROSONICS, LLC 2011-05-12 US disclosed
EP-2305779-A2 Method for desulfurization of hydrocarbon oils General Electric Company (US) 2011-04-06 EP disclosed
US-20110073526-A1 Method for Desulfurization of Hydrocarbon Oils GENERAL ELECTRIC COMPANY (US) 2011-03-31 US disclosed
US-7871512-B2 Treatment of crude oil fractions, fossil fuels, and products thereof PETROSONICS, LLC (US) 2011-01-18 US disclosed
US-7750156-B2 Method of producing aminophenol compounds OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2010-07-06 US disclosed
EP-2188314-A1 CONVERSION METHOD The Queens University of Belfast (GB) 2010-05-26 EP disclosed
US-7559241-B2 High-throughput continuous-flow ultrasound reactor SULPHCO, INC. (US) 2009-07-14 US disclosed
EP-1308443-B1 Method for the preparation of aryl ethers PHARMACIA & UPJOHN CO LLC (US) 2009-04-29 EP disclosed
EP-1668095-B1 TREATMENT OF CRUDE OIL FRACTIONS, FOSSIL FUELS, AND PRODUCTS THEREOF CULLEN MARK (US) 2009-03-18 EP disclosed
WO-2009030950-A1 CONVERSION METHOD THE QUEEN'S UNIVERSITY OF BELFAST (GB) 2009-03-12 WO disclosed
EP-2033974-A1 Conversion method The Queens University of Belfast (GB) 2009-03-11 EP disclosed
EP-2025736-A2 Treatment of crude oil fractions, fossil fuels, and products thereof Cullen, Mark (US) 2009-02-18 EP disclosed
EP-1848788-A4 UPGRADING OF PETROLEUM BY COMBINED ULTRASOUND AND MICROWAVE TREATMENTS SULPHCO INC (US) 2008-08-27 EP disclosed
US-20080067055-A1 High-Throughput Continuous-Flow Ultrasound Reactor SULPHCO, INC. (US) 2008-03-20 US disclosed
US-7300566-B2 Conversion of petroleum resid to usable oils with ultrasound SULPHCO, INC. (US) 2007-11-27 US disclosed
EP-1848788-A2 UPGRADING OF PETROLEUM BY COMBINED ULTRASOUND AND MICROWAVE TREATMENTS Sulphco, Inc. (US) 2007-10-31 EP disclosed
EP-1844831-A1 Treatment of crude oil fractions, fossil fuels, and products thereof with sonic energy Cullen, Mark (US) 2007-10-17 EP disclosed
US-20070219374-A1 Method of Producing Aminophenol Compounds OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2007-09-20 US disclosed
EP-1187833-B1 METHOD OF PRODUCING THIAMETHOXAM SYNGENTA PARTICIPATIONS AG (CH) 2007-06-06 EP disclosed
EP-1668095-A4 TREATMENT OF CRUDE OIL FRACTIONS, FOSSIL FUELS, AND PRODUCTS THEREOF CULLEN MARK (US) 2007-06-06 EP disclosed
EP-1748882-A2 HIGH-THROUGHPUT CONTINUOUS-FLOW ULTRASOUND REACTOR Sulphco, Inc. (US) 2007-02-07 EP disclosed
EP-1733007-A2 CONVERSION OF PETROLEUM RESID TO USABLE OILS WITH ULTRASOUND Sulphco, Inc. (US) 2006-12-20 EP disclosed
EP-1727782-A1 METHOD OF PRODUCING AMINOPHENOL COMPOUNDS OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2006-12-06 EP disclosed
WO-2006088567-A2 UPGRADING OF PETROLEUM BY COMBINED ULTRASOUND AND MICROWAVE TREATMENTS SULPHCO, INC. (US) 2006-08-24 WO disclosed
US-20060180500-A1 Upgrading of petroleum by combined ultrasound and microwave treatments SULPHCO, INC., A CORPORATION OF THE STATE OF NEVADA (US) 2006-08-17 US disclosed
EP-1635924-A4 TREATMENT OF CRUDE OIL FRACTIONS, FOSSIL FUELS, AND PRODUCTS THEREOF WITH SONIC ENERGY CULLEN MARK (US) 2006-07-26 EP disclosed
US-7081196-B2 Treatment of crude oil fractions, fossil fuels, and products thereof with sonic energy PETROSONICS, LLC 2006-07-25 US disclosed
US-20060157339-A1 Treatment of crude oil fractions, fossil fuels, and products thereof with sonic energy PETROSONICS, LLC 2006-07-20 US disclosed
EP-1668095-A2 TREATMENT OF CRUDE OIL FRACTIONS, FOSSIL FUELS, AND PRODUCTS THEREOF Cullen, Mark (US) 2006-06-14 EP disclosed
EP-1635924-A2 TREATMENT OF CRUDE OIL FRACTIONS, FOSSIL FUELS, AND PRODUCTS THEREOF WITH SONIC ENERGY Cullen, Mark (US) 2006-03-22 EP disclosed
WO-2005118277-A2 HIGH-THROUGHPUT CONTINUOUS-FLOW ULTRASOUND REACTOR SULPHCO, INC. (US) 2005-12-15 WO disclosed
US-20050274600-A1 High-throughput continuous-flow ultrasound reactor SULPHCO, INC. (US) 2005-12-15 US disclosed
WO-2005092832-A1 METHOD OF PRODUCING AMINOPHENOL COMPOUNDS OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2005-10-06 WO disclosed
WO-2005091859-A2 CONVERSION OF PETROLEUM RESID TO USABLE OILS WITH ULTRASOUND SULPHCO, INC. (US) 2005-10-06 WO disclosed
US-20050205463-A1 Conversion of petroleum resid to usable oils with ultrasound SULPHCO, INC. (US) 2005-09-22 US disclosed
US-20050182285-A1 Treatment of crude oil fractions, fossil fuels, and products thereof with sonic energy PETROSONICS, LLC 2005-08-18 US disclosed
US-20050167336-A1 Treatment of crude oil fractions, fossil fuels, and products thereof with sonic energy PETROSONICS, LLC 2005-08-04 US disclosed
WO-2005019383-A2 TREATMENT OF CRUDE OIL FRACTIONS, FOSSIL FUELS, AND PRODUCTS THEREOF CULLEN MARK (US) 2005-03-03 WO disclosed
EP-1335962-A4 OXIDATIVE DESULFURIZATION OF FOSSIL FUELS WITH ULTRASOUND SULPHCO INC (US) 2005-01-19 EP disclosed
WO-2004101100-A2 TREATMENT OF CRUDE OIL FRACTIONS, FOSSIL FUELS, AND PRODUCTS THEREOF WITH SONIC ENERGY CULLEN MARK (US) 2004-11-25 WO disclosed
US-20040181099-A1 Aromatic ethers and process for producing aromatic ethers NIPPON SHOKUBAI CO., LTD. (JP) 2004-09-16 US disclosed
US-6747146-B2 USING PHASE TRANSFER CATALYST AND QUATERNARY AMMONIUM COMPOUND SYNGENTA CROP PROTECTION, INC. 2004-06-08 US disclosed
US-20040074812-A1 Treatment of crude oil fractions, fossil fuels, and products thereof PETROSONICS, LLC 2004-04-22 US disclosed
US-20040035753-A1 Treatment of crude oil fractions, fossil fuels, and products thereof with sonic energy PETROSONICS, LLC 2004-02-26 US disclosed
EP-1140788-B1 METHOD FOR THE PREPARATION OF ARYL ETHERS UPJOHN CO (US) 2004-02-25 EP disclosed
EP-1366014-A1 METHOD AND CATALYST SYSTEM FOR PRODUCING AROMATIC CARBONATES GENERAL ELECTRIC COMPANY (US) 2003-12-03 EP disclosed
EP-1335962-A1 OXIDATIVE DESULFURIZATION OF FOSSIL FUELS WITH ULTRASOUND Sulphco.Inc. (US) 2003-08-20 EP disclosed
US-20030092915-A1 Method of producing nitroguanidine- and nitroenamine derivatives SYNGENTA CROP PROTECTION, INC. 2003-05-15 US disclosed
EP-1308443-A2 Method for the preparation of aryl ethers PHARMACIA & UPJOHN COMPANY (US) 2003-05-07 EP disclosed
US-20030051988-A1 Treatment of crude oil fractions, fossil fuels, and products thereof with ultrasound TALISMAN CAPITAL TALON FUND, LTD 2003-03-20 US disclosed
EP-0759915-B1 ASYMMETRIC SYNTHESIS OF CHIRAL SECONDARY ALCOHOLS CELL THERAPEUTICS INC (US) 2002-10-16 EP disclosed
WO-2002060854-A1 METHOD AND CATALYST SYSTEM FOR PRODUCING AROMATIC CARBONATES GENERAL ELECTRIC COMPANY (US) 2002-08-08 WO disclosed
US-6402939-B1 ACIDIC AQUEOUS SOLUTION SULPHCO, INC. 2002-06-11 US disclosed
US-6376711-B1 OXIDATION CINNAMYL ALCOHOL FORMING EPOXIDE; REACTING WITH PHENOL; SILYLATING; REACTING WITH AMMONIA PHARMACIA AND UPJOHN COMPANY 2002-04-23 US disclosed
WO-2002026916-A1 OXIDATIVE DESULFURIZATION OF FOSSIL FUELS WITH ULTRASOUND SULPHCO. INC. (US) 2002-04-04 WO disclosed
EP-1187833-A1 METHOD OF PRODUCING NITROGUANIDINE- AND NITROENAMINE DERIVATIVES Syngenta Participations AG (CH) 2002-03-20 EP disclosed
EP-1140788-A1 METHOD FOR THE PREPARATION OF ARYL ETHERS PHARMACIA & UPJOHN COMPANY (US) 2001-10-10 EP disclosed
WO-2001000623-A1 METHOD OF PRODUCING NITROGUANIDINE- AND NITROENAMINE DERIVATIVES SYNGENTA PARTICIPATIONS AG (CH) 2001-01-04 WO disclosed
WO-2000039072-A1 METHOD FOR THE PREPARATION OF ARYL ETHERS PHARMACIA & UPJOHN COMPANY (US) 2000-07-06 WO disclosed
US-6057328-A TREATING CONDITIONS RESULTING FROM HYPEROXIA, AND IN PARTICULAR, CONDITIONS RESULTING FROM THERAPEUTIC ADMINISTRATION OF OXYGEN COMPRISING ADMINISTERING XANTHINE COMPOUNDS CELL THERAPEUTICS, INC. (US) 2000-05-02 US disclosed
WO-1999033468-A9 METHOD FOR TREATING HYPEROXIA CELL THERAPEUTICS INC (US) 1999-09-23 WO disclosed
WO-1999033468-A1 METHOD FOR TREATING HYPEROXIA CELL THERAPEUTICS, INC. (US) 1999-07-08 WO disclosed
US-5629423-A Asymmetric synthesis of chiral secondary alcohols CELL THERAPEUTICS, INC. (US) 1997-05-13 US disclosed
EP-0759915-A1 ASYMMETRIC SYNTHESIS OF CHIRAL SECONDARY ALCOHOLS CELL THERAPEUTICS, INC. (US) 1997-03-05 EP disclosed
WO-1995031450-A1 ASYMMETRIC SYNTHESIS OF CHIRAL SECONDARY ALCOHOLS CELL THERAPEUTICS, INC. (US) 1995-11-23 WO disclosed
JP-H04227856-A RECOVERY OF PHASE TRANSFER CATALYST ETHYL CORP 1992-08-17 JP disclosed
US-4885404-A HIGH YIELDS THE UPJOHN COMPANY (US) 1989-12-05 US disclosed
EP-0263205-A1 Processes for the preparation of compounds comprising substituted phenyl rings THE UPJOHN COMPANY (US) 1988-04-13 EP disclosed
EP-0231257-A1 CHEMICAL COMPOUNDS COMRPISING SUBSTITUTED PHENYLRINGS THE UPJOHN COMPANY (US) 1987-08-12 EP disclosed
WO-1987000519-A1 CHEMICAL COMPOUNDS COMRPISING SUBSTITUTED PHENYLRINGS THE UPJOHN COMPANY (US) 1987-01-29 WO disclosed
US-4009116-A Process of preparing substantially organic waste liquids containing radioactive or toxic substances for safe, non-pollutive handling, transportation and permanent storage BAYER AKTIENGESELLSCHAFT (DT) 1977-02-22 US disclosed
US-3960762-A Production of absorbents BAYER AKTIENGESELLSCHAFT (DT) 1976-06-01 US disclosed
US-3960762-A Production of absorbents BAYER AKTIENGESELLSCHAFT (DT) 1976-06-01 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (18 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210246117-A1 PROCESSES FOR MAKING MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR CFTR, SCNN1B, SCNN1G FDPS 185/4885TSHR 2590/4885LMNA 3683/4885
US-20120149899-A1 PROCESS FOR PRODUCING BENZO[B][1,4]DIAZEPINE-2,4-DIONE COMPOUND KCNH1, KCNB2, KCNJ2 FDPS 1199/4885TSHR 792/4885LMNA 1230/4885
US-20070219374-A1 Method of Producing Aminophenol Compounds PAH, CYP1A1, CYP1B1 FDPS 486/4885TSHR 1015/4885LMNA 4194/4885
US-20260125363-A1 PROCESSES FOR MAKING MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR CFTR, SLC26A4, SLC26A3 FDPS 731/4885TSHR 1602/4885LMNA 1827/4885
US-20040181099-A1 Aromatic ethers and process for producing aromatic ethers XDH, FTO, CYP4F8 FDPS 422/4885TSHR 1258/4885LMNA 4621/4885
US-10971718-B2 Electrochemical energy storage devices PC, PANK2, MCU FDPS 2837/4885TSHR 3160/4885LMNA 1061/4885
US-11173102-B1 Methods and compositions for removing color from color-treated hair TYR, POLR1C, CYCS FDPS 4805/4885TSHR 3222/4885LMNA 1542/4885
US-20240025877-A1 PROCESSES FOR MAKING MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR CFTR, SCNN1B, SCNN1G FDPS 213/4885TSHR 2866/4885LMNA 3445/4885
US-20140194621-A1 PROCESS FOR PRODUCING BENZO [B] [1,4] DIAZEPINE-2, 4-DIONE COMPOUND KCNH1, KCNB2, KCNB1 FDPS 1812/4885TSHR 608/4885LMNA 1061/4885
US-11465985-B2 Processes for making modulators of cystic fibrosis transmembrane conductance regulator CFTR, SCNN1B, SCNN1G FDPS 185/4885TSHR 2590/4885LMNA 3683/4885
US-11154479-B1 Methods of removing color from color-treated hair TYR, IK, HLA-C FDPS 4853/4885TSHR 3094/4885LMNA 1953/4885
US-12415798-B2 Processes for making modulators of cystic fibrosis transmembrane conductance regulator CFTR, SCNN1B, SCNN1G FDPS 213/4885TSHR 2866/4885LMNA 3445/4885
US-20210369582-A1 METHODS AND COMPOSITIONS FOR REMOVING COLOR FROM COLOR-TREATED HAIR TYR, POLR1C, CYCS FDPS 4805/4885TSHR 3222/4885LMNA 1542/4885
US-20240368123-A1 AROMATIC RING-CONTAINING BIOLOGICAL ANTAGONIST, AND PREPARATION METHOD THEREFOR AND USE THEREOF REN, BDKRB2, BDKRB1 FDPS 1379/4885TSHR 1309/4885LMNA 2702/4885
US-20030092915-A1 Method of producing nitroguanidine- and nitroenamine derivatives CBR1, CBR3, NOX1 FDPS 2411/4885TSHR 853/4885LMNA 1301/4885
US-10481456-B2 Electrochemical energy storage devices PC, PANK2, VDAC2 FDPS 2935/4885TSHR 3524/4885LMNA 1699/4885
US-20120029247-A1 CONVERSION METHOD AGL, PHYKPL, C5 FDPS 1893/4885TSHR 4490/4885LMNA 158/4885
US-20140296572-A1 PROCESSES FOR THE PREPARATION OF LACOSAMIDE AND INTERMEDIATES THEREOF CA3, TREH, NAAA FDPS 327/4885TSHR 3999/4885LMNA 483/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.